Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) | WebDisclosure

Basculer en Français

9480	Companies
185531	Keywords
117925	Articles
99377	Press releases

Headlines Articles Press releases Aspire Biopharma Holdings, Inc.

Home
Companies
Aspire Biopharma Holdings, Inc.

BRIEF

published on 11/06/2025 at 15:05, 29 days 4 hours ago

Aspire Biopharma Initiates Partnership Discussions at CPHI Frankfurt

Pharmaceutical Partnerships Drug Delivery Technology Aspire Biopharma Sublingual Aspirin CPHI Frankfurt
PRESS RELEASE

published on 11/06/2025 at 15:00, 29 days 4 hours ago

Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin
Aspire Biopharma successfully participated in CPHI Frankfurt, engaging in strategic discussions with global pharma companies for its innovative sublingual high-dose aspirin. The event hosted 63,000+ attendees from 160 countries

Drug Delivery Technology Aspire Biopharma CPHI Frankfurt Sublingual High-dose Aspirin Pharmaceutical Event
BRIEF

published on 09/03/2025 at 14:35, 3 months 2 days ago

Aspire Biopharma franchit une étape clé avec un essai sur l'aspirine sublinguale pour le traitement des crises cardiaques

Essai Clinique Approbation De La FDA Aspirine Sublinguale Traitement De La Crise Cardiaque Inhibition De La Thromboxane B2
BRIEF

published on 09/03/2025 at 14:35, 3 months 2 days ago

Aspire Biopharma Achieves Key Milestone with Sublingual Aspirin Trial for Heart Attack Treatment

FDA Approval Clinical Trial Sublingual Aspirin Heart Attack Treatment Thromboxane B2 Inhibition
PRESS RELEASE

published on 09/03/2025 at 14:30, 3 months 2 days ago

Aspire Biopharma Announces Breakthrough Final Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)
Aspire's sublingual aspirin formulation rapidly inhibits blood clotting by blocking platelet aggregation, showing potential for accelerated approval in Q3 2025

Clinical Trial Sublingual Aspirin Aspire TxB2 Inhibition Heart Attack
BRIEF

published on 08/13/2025 at 15:15, 3 months 23 days ago

Aspire Biopharma Launches BUZZ BOMB™ Pre-Workout Supplement

Consumer Outreach Aspire Biopharma Pre-workout Supplement Fitness Conventions BUZZ BOMB™ Launch
BRIEF

published on 08/13/2025 at 15:15, 3 months 23 days ago

Aspire Biopharma lance le complément pré-entraînement BUZZ BOMB™

Aspire Biopharma Supplément Pré-entraînement Conventions De Fitness Lancement De BUZZ BOMB™ Sensibilisation Des Consommateurs
PRESS RELEASE

published on 08/13/2025 at 15:10, 3 months 23 days ago

Aspire Biopharma Successfully Launches BUZZ BOMB(TM) Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World
Aspire's BUZZ BOMB™ sublingual pre-workout supplement with 50mg of caffeine in four flavors showcased at FitCon and FitExpo, impressing fitness experts and consumers for its rapid delivery technology and convenience

Aspire Sublingual BUZZ BOMB FITCON Pre-workout

Accesswire

Published on 12/05/2025 at 19:20, 23 minutes ago

The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 58 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 1 hour 23 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 1 hour 43 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 2 hours 28 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 45 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 1 hour 17 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 1 hour 28 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 1 hour 51 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 1 hour 57 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 2 hours 25 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 2 hours 25 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 4 hours 32 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 4 hours 32 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 5 hours 45 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE